{
    "2018-05-08": [
        [
            {
                "time": "2018-04-25",
                "original_text": "How Analysts View Allergan after Its 1Q18 Earnings",
                "features": {
                    "keywords": [
                        "Allergan",
                        "1Q18",
                        "Earnings",
                        "Analysts"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-26",
                "original_text": "A Look at Abbott Laboratoriesâ€™ Valuation Multiples",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Laboratories",
                        "Valuation",
                        "Multiples"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}